Practising Law
Institute (PLI) will be holding a seminar entitled "Developments in
Pharmaceutical and Biotech Patent Law 2010" on September 16, 2010 in New
York, NY.  Groupcasts
of the New York session will also be held in Philadelphia, PA; Pittsburgh, PA;
Mechanicsburg, PA; New Brunswick, NJ; and Boston, MA.  At the
seminar, PLI faculty will discuss:

• The top
pharmaceutical and biotech decisions from 2010;
• Continued
developments in the law governing the patentability of active pharmaceutical
products from the Federal Circuit and District Court perspectives;
• Section 112
developments regarding enablement and written description requirements and how
they apply to compounds, antibodies, nucleic acids, methods of treatment, and
pharmaceutical compositions;
• Section 101
developments on utility and patentable subject matter; and
• How to integrate
changes in the law from 2010 into prosecution strategies and practices.

In particular, PLI
faculty will offer presentations on the following topics:

• Section 101:  Redefining patentable subject matter
and utility and the impact on pharmaceutical and biotech patents;
• The age of
written description and enablement;
• Navigating
follow-on biologics legislation;
• Maximizing patent
term:  Pointers & pitfalls;
• Recent
developments in the law of patent remedies; and
• Recent changes in
patent prosecution practice.

A detailed program
for the Developments in Pharmaceutical and Biotech Patent Law seminar can be
found here. 
The registration fee for the seminar is $1,495. Those interested in
registering for the conference can do so here (New York).  Those interested in
registering for the Groupcasts can do so here (Philadelphia, PA), here
(Pittsburgh, PA), here (Mechanicsburg, PA), here (New Brunswick, NJ), or here
(New Brunswick, NJ).